As @WHO readies launch of patent pool for #COVID19 products, top pharma execs push back on the idea as a "dangerous" disincentive that won't help access. My colleague and noted Twins fans @StephenPHansen explains their thinking. $GSK $PFE $AZN $JNJ  https://t.co/5Fv0Fp3h1M